Inspire Medical Systems (INSP) Research & Development (2017 - 2025)
Inspire Medical Systems (INSP) has disclosed Research & Development for 9 consecutive years, with $24.9 million as the latest value for Q4 2025.
- Quarterly Research & Development fell 17.78% to $24.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $103.2 million through Dec 2025, down 9.61% year-over-year, with the annual reading at $103.2 million for FY2025, 9.61% down from the prior year.
- Research & Development hit $24.9 million in Q4 2025 for Inspire Medical Systems, up from $24.2 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $31.1 million in Q4 2023 to a low of $8.2 million in Q1 2021.
- Historically, Research & Development has averaged $22.0 million across 5 years, with a median of $25.2 million in 2023.
- Biggest five-year swings in Research & Development: soared 118.36% in 2022 and later fell 17.78% in 2025.
- Year by year, Research & Development stood at $10.3 million in 2021, then surged by 106.41% to $21.2 million in 2022, then soared by 46.14% to $31.1 million in 2023, then dropped by 2.31% to $30.3 million in 2024, then decreased by 17.78% to $24.9 million in 2025.
- Business Quant data shows Research & Development for INSP at $24.9 million in Q4 2025, $24.2 million in Q3 2025, and $26.2 million in Q2 2025.